BeOne Medicines (BGNE) Q2 2025 Earnings Call August 06, 2025 08:00 AM ET Company ParticipantsDaniel Maller - VP - Investor RelationsJohn Oyler - Co-Founder, Chairman & CEOAaron Rosenberg - CFOLai Wang - Global Head of R&DMatt Shaulis - General Manager - North AmericaMark Lanasa - SVP & Chief Medical Officer - Solid TumorsSean Laaman - Executive DirectorYigal Nochomovitz - DirectorXiaobin Wu - President & COOReni Benjamin - Managing DirectorConference Call ParticipantsJessica Fye - MD & Equity Research Analy ...

BeOne Medicines (BGNE) Q2 2025 Earnings Call August 06, 2025 08:00 AM ET Speaker0Day, everyone. Welcome to B1 Q2 twenty twenty five Earnings Call Webcast. Lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question and answer session. At this time, I would like to turn the call over to the company.Speaker1Hello, and welcome. Thanks for joining us today. I'm Dan Mallard, Head of Investor Relations at B1 Medicines. Before we begin, please note that you ...